Type
Internal restructuring
Country
Netherlands
Region
Zuid-Nederland; Noord-Brabant; Noordoost-Noord-Brabant
Location of affected unit(s)
Oss
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.2 - Manufacture of pharmaceutical preparations

580 jobs
Number of planned job losses
Job loss
Announcement Date
30 January 2014
Employment effect (start)
1 July 2014
Foreseen end date
31 December 2016

Description

On 30 January 2014 pharmaceutical group MSD announced it would cut 580 jobs between mid 2014 and the end of 2016. All job cuts will take place in the research centre located in Oss. The first announcement for 140 job losses was made in November 2013; the number now has risen to 580. After the restructuring 30 jobs will remain in research as well as 1500 in the production lines. The measure is part of a world wide restructuring operation by MSD (see factsheet 25470) and comes on top of earlier restructuring in Oss after the acquisition by MSD in 2010 (see factsheet 17821).


Sources

  • 1 February 2014: Het Financieele Dagblad
  • 31 January 2014: Het Financieele Dagblad

Citation

Eurofound (2014), MSD, Internal restructuring in Netherlands, factsheet number 76528, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/76528.